A detailed history of Schroder Investment Management Group transactions in Becton Dickinson & CO stock. As of the latest transaction made, Schroder Investment Management Group holds 31,136 shares of BDX stock, worth $7.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
31,136
Previous 34,918 10.83%
Holding current value
$7.28 Million
Previous $8.16 Million 8.01%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$221.47 - $242.41 $837,599 - $916,794
-3,782 Reduced 10.83%
31,136 $7.51 Million
Q2 2024

Aug 12, 2024

SELL
$225.07 - $246.17 $560,199 - $612,717
-2,489 Reduced 6.65%
34,918 $8.16 Million
Q1 2024

May 14, 2024

BUY
$233.45 - $247.73 $287,610 - $305,203
1,232 Added 3.41%
37,407 $9.26 Million
Q4 2023

Feb 13, 2024

SELL
$232.24 - $267.23 $17.1 Million - $19.7 Million
-73,692 Reduced 67.07%
36,175 $8.82 Million
Q3 2023

Nov 14, 2023

BUY
$254.9 - $283.59 $19.8 Million - $22 Million
77,743 Added 242.01%
109,867 $28.4 Million
Q2 2023

Aug 11, 2023

SELL
$238.39 - $265.32 $952,606 - $1.06 Million
-3,996 Reduced 11.06%
32,124 $8.48 Million
Q1 2023

May 11, 2023

SELL
$229.71 - $259.35 $2.59 Million - $2.92 Million
-11,273 Reduced 23.79%
36,120 $8.94 Million
Q4 2022

Feb 10, 2023

SELL
$218.29 - $256.91 $13,315 - $15,671
-61 Reduced 0.13%
47,393 $12.1 Million
Q3 2022

Nov 10, 2022

SELL
$51.03 - $264.23 $679,566 - $3.52 Million
-13,317 Reduced 21.91%
47,454 $10.6 Million
Q2 2022

Aug 11, 2022

BUY
$234.74 - $275.42 $5.73 Million - $6.72 Million
24,405 Added 67.11%
60,771 $15.2 Million
Q1 2022

May 16, 2022

SELL
$243.64 - $270.48 $14.6 Million - $16.2 Million
-59,822 Reduced 62.19%
36,366 $9.8 Million
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $2.67 Million - $2.91 Million
11,600 Added 13.71%
96,188 $24.2 Million
Q3 2021

Nov 12, 2021

BUY
$232.72 - $256.47 $13.7 Million - $15.1 Million
58,791 Added 227.9%
84,588 $20.8 Million
Q2 2021

Aug 13, 2021

BUY
$232.65 - $254.58 $756,112 - $827,385
3,250 Added 14.41%
25,797 $6.27 Million
Q1 2021

May 17, 2021

BUY
$232.09 - $256.88 $2.19 Million - $2.42 Million
9,438 Added 72.0%
22,547 $5.48 Million
Q4 2020

Feb 16, 2021

BUY
$221.92 - $245.94 $218,369 - $242,004
984 Added 8.12%
13,109 $3.28 Million
Q3 2020

Nov 13, 2020

SELL
$215.77 - $276.76 $2.95 Million - $3.78 Million
-13,666 Reduced 52.99%
12,125 $2.82 Million
Q2 2020

Aug 13, 2020

BUY
$219.9 - $263.41 $2.71 Million - $3.25 Million
12,320 Added 91.46%
25,791 $6.17 Million
Q1 2020

May 15, 2020

BUY
$195.69 - $279.01 $1.69 Million - $2.4 Million
8,614 Added 177.35%
13,471 $3.2 Million
Q4 2019

Feb 11, 2020

SELL
$236.45 - $266.82 $8.29 Million - $9.36 Million
-35,069 Reduced 87.83%
4,857 $1.32 Million
Q3 2019

Nov 12, 2019

BUY
$230.58 - $256.08 $92,232 - $102,432
400 Added 1.01%
39,926 $9.9 Million
Q2 2019

Aug 08, 2019

SELL
$217.4 - $246.08 $709,158 - $802,712
-3,262 Reduced 7.62%
39,526 $9.96 Million
Q1 2019

May 14, 2019

SELL
$206.05 - $248.17 $1.56 Million - $1.88 Million
-7,574 Reduced 15.04%
42,788 $10.7 Million
Q4 2018

Feb 14, 2019

SELL
$204.73 - $257.93 $48,930 - $61,645
-239 Reduced 0.47%
50,362 $11.3 Million
Q3 2018

Nov 13, 2018

BUY
$233.07 - $256.0 $3.02 Million - $3.32 Million
12,963 Added 34.44%
50,601 $13.2 Million
Q2 2018

Aug 13, 2018

SELL
$208.1 - $233.85 $904,610 - $1.02 Million
-4,347 Reduced 10.35%
37,638 $9.02 Million
Q1 2018

May 11, 2018

BUY
$205.46 - $240.27 $108,688 - $127,102
529 Added 1.28%
41,985 $9.1 Million
Q4 2017

Feb 09, 2018

BUY
$189.0 - $222.64 $53,109 - $62,561
281 Added 0.68%
41,456 $8.87 Million
Q3 2017

Nov 09, 2017

BUY
$186.89 - $198.9 $7.7 Million - $8.19 Million
41,175
41,175 $7.97 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $66.6B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.